GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teyi Pharmaceutical Group Co Ltd (SZSE:002728) » Definitions » Deferred Tax

Teyi Pharmaceutical Group Co (SZSE:002728) Deferred Tax : ¥0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Teyi Pharmaceutical Group Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Teyi Pharmaceutical Group Co's change in deferred tax for the three months ended in Sep. 2024 was ¥0.0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.0 Mil.

Teyi Pharmaceutical Group Co Deferred Tax Historical Data

The historical data trend for Teyi Pharmaceutical Group Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teyi Pharmaceutical Group Co Deferred Tax Chart

Teyi Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Teyi Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Teyi Pharmaceutical Group Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teyi Pharmaceutical Group Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Teyi Pharmaceutical Group Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Teyi Pharmaceutical Group Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teyi Pharmaceutical Group Co Ltd (SZSE:002728) » Definitions » Deferred Tax
Comparable Companies
SZSE:300401 SZSE:300194 SHSE:688566 SHSE:600488 SHSE:688073 SZSE:000566 SZSE:300485 SHSE:688247 SHSE:600789 SHSE:603520 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 9, 11, Changxing Road, Taicheng, Guangdong Province, Taishan, CHN, 529200
Website
http://www.tczy.com.cn
Teyi Pharmaceutical Group Co Ltd is engaged in Research and development, production and sales of traditional Chinese medicines and chemical preparations.
Executives
Zhang Yong Zhao Executives
Chen Xi Liang Directors, Directors, and Executives
Xu Shao Hua Securities Affairs Representative
Xu Wei Gao Director
Xu Song Qing Directors, executives
Liu Guang Tao Executives
Du Yong Chun Supervisors
Huang Yan Ling Executives
Chen Guang Ting Supervisors

Teyi Pharmaceutical Group Co Headlines

No Headlines